Latest filing published 25 Aug 2026 for Naturhouse Health, S.A.. Read the official filing
First 200 filings with a declared amount
Based on 172 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ferev UNO Strategic Plans, S.L. is a declared insider of Naturhouse Health, S.A., with filings sourced from CNMV. In total, 354 filings cover trades dated from 24 June 2021 to 25 August 2026.
The open-market side counts 194 purchases for €837k alongside 28 sales for €550k. Purchases outweigh sales by €287k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings no purchases and 14 sales.
A typical purchase (the median) is worth €4,068. As a share of market capitalisation, the median purchase stands at 0.0027%, based on 194 purchases. Clusters matter here: 87 out of 192 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 172 purchases old enough to measure, the stock rose over the following 90 days in 78% of cases; the median change was +3.4%. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 25 August 2026: a transaction, in Naturhouse Health, S.A. The clock since the last published purchase (8 October 2025) now reads 375 days. Filings reach the CNMV feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by CNMV. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 354 declarations